Document ID: EPA-HQ-OAR-2006-0159-0020
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2006-11-03T05:00Z

Decision XVII/5: Essential-use nominations for Parties not operating
under

paragraph 1 of Article 5 for controlled substances for 2006 and 2007

Noting with appreciation the work done by the Technology and Economic
Assessment Panel and its Medical Technical Options Committee,

Noting with appreciation the progress made since the adoption of
decision XV/5 by Parties not operating under paragraph 1 of Article 5 of
the Montreal Protocol in establishing a certain date by which they will
cease submitting nominations for metered-dose inhalers where the sole
active ingredient is salbutamol,

Recalling paragraph 6 of decision XV/5 relating to the phase-out of
chlorofluorocarbons for metered-dose inhalers where the active
ingredient is not solely salbutamol,

1. To authorize the levels of production and consumption for 2006 and
2007 necessary to satisfy essential uses of chlorofluorocarbons for
metered-dose inhalers for asthma and chronic obstructive pulmonary
disease as specified in the annex to the present decision;

2. That Parties not operating under paragraph 1 of Article 5 of the
Montreal Protocol, when licensing, authorizing, or allocating
essential-use exemptions for chlorofluorocarbons for a manufacturer,
shall take into account pre- and post-1996 stocks of controlled
substances as described in paragraph 1 (b) of decision IV/25, such that
no more than a one-year operational supply is maintained by that
manufacturer;

3. With reference to paragraph 6 of decision XV/5, to request that
Parties not operating under paragraph 1 of Article 5 of the Montreal
Protocol submit a date to the Ozone Secretariat prior to the Eighteenth
Meeting of the Parties by which time a regulation or regulations to
determine the non-essentiality of the vast majority of
chlorofluorocarbons for metered-dose inhalers where the active
ingredient is not solely salbutamol will have been proposed;

Annex

Essential-use nominations for 2006 and 2007 of chlorofluorocarbons for

metered-dose inhalers approved by the Seventeenth Meeting of the Parties

(metric tonnes)

Party		2006	2007

	Amount nominated	Amount approved	Amount nominated	Amount approved

European Community	539	539	-	-

Russian Federation	400	400	243	243

United States of America	1702	1100	1493	1000